Skip to content

Internet of things based community pulmonary rehabilitation system study

Internet of things based community pulmonary rehabilitation system study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043577
Enrollment
Unknown
Registered
2021-02-23
Start date
2021-02-23
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Test group:pulmonary rehabilitation
Control group:Conventional treatment

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) male or female patients aged between 40 and 80 years; 2) according to the GOLD standard, the pulmonary function was classified as GOLD2-4; 3) stable phase of COPD (discharge > 3 weeks); 4) voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) pregnant women; 2) patients with severe organ insufficiency (heart failure, liver failure, renal failure); 3) patients with severe pulmonary vesicles; 4) patients with severe thoracic and abdominal aortic aneurysms; 5) patients with advanced malignant tumor; 6) patients with pneumothorax and pneumothorax within 1 month after healing; 7) patients with unstable angina pectoris and recent myocardial infarction; 8) patients with severe hypertension and hypertensive crisis; 9) those who are unable to cooperate with or affect their activities (such as long-term bedridden, severe malnutrition, arterial disease of lower extremities, recent fractures or major thoracic and abdominal surgery, hemiplegia, facial paralysis, cerebrovascular accidents, myasthenia gravis, mental illness, cerebral palsy and mental retardation). 10) hemoptysis within two weeks; 11) patients with open pulmonary tuberculosis and all patients with infectious diseases; 12) patients with gastrointestinal bleeding in active stage; 13) patients with indwelling gastric tube; 14) patients with tracheotomy; 15) patients with severe thoracic and spinal deformities; 16) other active diseases that may affect the results of the study; 17) situations where other doctors do not consider it appropriate to join a study or perform respiratory rehabilitation.

Design outcomes

Primary

MeasureTime frame
Readmission rate or number of acute exacerbations / 3 months;Quality of life (SGRQ);

Secondary

MeasureTime frame
Activity ability (6-minute walking distance);Symptoms (CAT score, MMRC);Accuracy and compliance of patients using inhaled drugs;To verify the effectiveness of each module process of respiratory rehabilitation management platform for community patient rehabilitation management.;

Countries

china

Contacts

Public ContactHongmei Zhao

North Campus, China-Japan Friendship Hospital

lucy0500@163.com+86 13701135896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026